Reappraisal of the clinical effect of mepolizumab - Authors' reply
- PMID: 28664853
- DOI: 10.1016/S2213-2600(17)30184-4
Reappraisal of the clinical effect of mepolizumab - Authors' reply
Comment on
-
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.Lancet Respir Med. 2017 May;5(5):390-400. doi: 10.1016/S2213-2600(17)30125-X. Epub 2017 Apr 5. Lancet Respir Med. 2017. PMID: 28395936 Clinical Trial.
-
Reappraisal of the clinical effect of mepolizumab.Lancet Respir Med. 2017 Jun;5(6):e20. doi: 10.1016/S2213-2600(17)30183-2. Epub 2017 May 26. Lancet Respir Med. 2017. PMID: 28664852 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources